Crystal Amber (CRS:121.5p), the best-performing UK small-cap closed-end fund over the past 12 months has released an ...

Morphic Therapeutic has lost Johnson & Johnson's Janssen Pharma as a partner, following the termination of an alliance to develop drugs targeting integrins first agreed in 2019. In a filing with ...

Shares of Morphic Holding Inc. rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly & Co. in a cash deal valued at about $3.2 billion.

Researchers from Morphic Therapeutic Inc. and affiliated organizations published data from a study that aimed to assess the potential of using arginylglycylaspartic acid (RGD) integrins for the ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Morphic Ethical ...

Investing in global listed securities screened to exclude entities involved in environmentally damaging activities (including coal and uranium, mining and oil and gas), intensive farming and ...

Assess today's live Morphic Holding Inc (MORF) share price, performance and insights using our live NASDAQ: MORF stock exchange data. Analyse the historical data and Morphic Holding Inc share price ...

Eli Lilly has bolstered its inflammatory bowel disease (IBD) pipeline with a $3.2 billion bid to acquire Morphic and its mid-stage oral integrin therapy MORF-057. Lilly is launching a tender offer ...